| 标题 |
Development and validation of a modified albumin–bilirubin grade and α-fetoprotein score (mALF score) for hepatocellular carcinoma patients receiving atezolizumab and bevacizumab |
| 网址 | |
| DOI | |
| 其它 |
期刊:Hepatology International 作者:Takeshi Hatanaka; Satoru Kakizaki; Atsushi Hiraoka; Toshifumi Tada; Masashi Hirooka; et al 出版日期:2022-09-09 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)